2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 2 Phase 4, 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Placebo Control Design: new trials by email Literature Review of Placebo Control Design trials Research Report on Placebo Control Design
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extracorporeal Shock Wave Therapy in Lower Extremity Lymphedema Extracorporeal Shock Wave Therapy (ESWT), Sham Extracorporeal Shock Wave Therapy (Sham ESWT) - Lymphedema, Lower Limb, Extracorporeal Shock Wave Therapy | Not applicable | Recruiting | Gazi University | 36 | 2026-09-01 | 2026-09-15 |
| SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial SGLT2i, Placebo - Kidney Transplant Recipient, Sodium Glucose Co-Transporter 2 Inhibitors | Phase 2 | Not yet recruiting | Odense University Hospital | 184 | 2026-09-01 | 2026-07-02 |
| SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients SGLT-2 inhibitor, Placebo - Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Recruiting | Odense University Hospital | 88 | 2025-09-01 | 2025-08-27 |
| Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension JARDIANCE 25mg, Placebo - Kidney Transplantation Recipients, Magnetic Resonance Imaging (MRI) | Phase 4 | Active not recruiting | Odense University Hospital | 8 | 2025-03-27 | 2025-07-31 |
| Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine trivalent rotavirus genetic reassortment vaccine, Placebo - Randomized, Double-blind | Phase 3 | Unknown | Center for Disease Control and Prevention, Henan Province | 10020 | 2012-08-01 | 2012-11-30 |
Lymphedema (1)
Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1)
Extracorporeal Shockwave Therapy (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · dapagliflozin (1) · empagliflozin (1)
Odense University Hospital (3) · Center for Disease Control and Prevention, Henan Province (1) · Gazi University (1)
Denmark (3) · Turkey (Türkiye) (1)